Legend Biotech
(NASDAQ) LEGN
Legend Biotech Financials at a Glance
Market Cap
$3.35B
Revenue (TTM)
$1.03B
Net Income (TTM)
$297.02M
EPS (TTM)
$-1.62
P/E Ratio
-11.19
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$19.05
Volume
37,801
Open
$18.39
Price
$19.05
Volume
37,801
Open
$18.39
Previous Close
$19.05
Daily Range
$18.39 - $19.20
52-Week Range
$16.24 - $45.30
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$19.05
Volume
37,801
Open
$18.39
Previous Close
$19.05
Daily Range
$18.39 - $19.20
52-Week Range
$16.24 - $45.30
LEGN News
LEGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Legend Biotech
Industry
Biotechnology
Sector
Health CareEmployees
2,900
CEO
Ying Huang, PhD
Website
www.legendbiotech.comHeadquarters
Somerset, NJ 08873, US
LEGN Financials
Key Financial Metrics (TTM)
Gross Margin
60%
Operating Margin
-13%
Net Income Margin
-29%
Return on Equity
-29%
Return on Capital
-12%
Return on Assets
-17%
Earnings Yield
-8.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.35B
Shares Outstanding
184.94M
Volume
37.80K
Short Interest
0.00%
Avg. Volume
2.28M
Financials (TTM)
Gross Profit
$622.44M
Operating Income
$136.86M
EBITDA
$107.78M
Operating Cash Flow
$100.47M
Capital Expenditure
$67.58M
Free Cash Flow
$168.04M
Cash & ST Invst.
$948.60M
Total Debt
$413.70M
Legend Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$307.64M
+64.9%
Gross Profit
$183.60M
+63.1%
Gross Margin
59.68%
N/A
Market Cap
$3.35B
N/A
Market Cap/Employee
$1.29M
N/A
Employees
2,600
N/A
Net Income
$31.03M
-218.1%
EBITDA
$7.73M
-114.7%
Quarterly Fundamentals
Net Cash
$534.90M
-30.7%
Accounts Receivable
$250.30M
+100.4%
Inventory
$32.00M
+33.9%
Long Term Debt
$87.20M
-74.8%
Short Term Debt
$326.50M
+6710.6%
Return on Assets
-17.13%
N/A
Return on Invested Capital
-12.37%
N/A
Free Cash Flow
$126.56M
-49.9%
Operating Cash Flow
$105.64M
-28.7%